Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy

By López Eugenio   Gunby Joanne   Daya Salim   Parrilla Juan J   Abad Lorenzo   Balasch Juan  

Reproductive BioMedicine Online, Vol. 9, Iss. 4, 2004-10 ,pp. : 382-390

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Ovarian Stimulation in Obese and Non-obese Polycystic Ovary Syndrome Using a Low-dose Step-up Regimen with Two Different Starting Doses of Recombinant Follicle-stimulating Hormone

By Yildizhan R   Adali E   Kolusari A   Kurdoglu M   Yildizhan B   Sahin HG   Kamaci M  

The Journal of International Medical Research, Vol. 36, Iss. 6, 2008-11 ,pp. : 1197-1204

Field House Publishing

Access to resources Recommend Favorite

Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness

By Gerli Sandro   Casini Maria Luisa   Unfer Vittorio   Costabile Loredana   Mignosa Marcella   Di Renzo Gian Carlo  

Reproductive BioMedicine Online, Vol. 9, Iss. 5, 2004-11 ,pp. : 494-499

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Metformin dose not provide additional benefit to clomifene for ovulation induction in patients with newly diagnosed polycystic ovary syndrome

By  

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

HMG versus rFSH for ovulation induction in developing countries: a cost–effectiveness analysis based on the results of a recent meta-analysis

By Al-Inany Hesham G   Abou-Setta Ahmed M   Aboulghar Mohamed A   Mansour Ragaa T   Serour Gamal I  

Reproductive BioMedicine Online, Vol. 12, Iss. 2, 2006-02 ,pp. : 163-169

Reproductive Healthcare Ltd

Access to resources Recommend Favorite